Sarman Singh
Overview
Explore the profile of Sarman Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
2955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shrivas A, Singh S, Singh J, Shankar P, Soni P, Rufai S, et al.
Microbiol Spectr
. 2025 Feb;
13(3):e0223624.
PMID: 39902977
Importance: Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide, killing millions every year. The emergence of multidrug-resistant and extensively drug-resistant TB forms poses a challenge to the...
2.
Singh S, Sankar M, Singh J, Rufai S, Kumar P, Kabra S, et al.
Indian J Pediatr
. 2025 Feb;
PMID: 39891887
In tuberculous meningitis (TBM) the paucibacillary nature of the cerebrospinal fluid (CSF) and low sample volume pose a major challenge, especially in young children and low volume samples are often...
3.
Bhusal C, Beniwal P, Singh S, Kaur D, Kaur U, Kaur S, et al.
Indian J Med Res
. 2024 Dec;
160(5):466-478.
PMID: 39737513
Background & objectives The emergence of drug resistance in leishmaniasis has remained a concern. Even new drugs have been found to be less effective within a few years of their...
4.
Pelzer P, Stuck L, Martinez L, Richards A, Acuna-Villaorduna C, Aronson N, et al.
Lancet Microbe
. 2024 Dec;
6(2):100961.
PMID: 39709975
Background: Tuberculosis vaccine trials using disease as the primary endpoint are large, time consuming, and expensive. An earlier immunological measure of the protection against disease would accelerate tuberculosis vaccine development....
5.
6.
Biduri N, Nandan D, Hooda R, Singh S
Indian J Pediatr
. 2024 Aug;
91(12):1289.
PMID: 39143394
No abstract available.
7.
Rizvi M, Malhotra S, Agarwal J, Siddiqui A, Devi S, Poojary A, et al.
IJID Reg
. 2024 May;
11:100370.
PMID: 38812702
Objectives: Evidence-based prescribing is essential to optimize patient outcomes in cystitis. This requires knowledge of local antibiotic resistance rates. Diagnostic and Antimicrobial Stewardship (DASH) to Protect Antibiotics (https://dashuti.com/) is a...
8.
Sehgal I, Agarwal R, Jindal A, Siddiqui M, Mohan A, Pal A, et al.
Lung India
. 2024 May;
41(2):84-92.
PMID: 38700400
Background: Mycobacterium w (Mw), an immunomodulator, resulted in better clinical status in severe coronavirus infectious disease 19 (COVID-19) but no survival benefit in a previous study. Herein, we investigate whether...
9.
Dubhashi S, Sinha S, Dwivedi S, Ghanekar J, Kadam S, Samant P, et al.
Cureus
. 2023 Sep;
15(8):e43731.
PMID: 37727187
Background/objective Cordyceps enhances animal survival against influenza by boosting the immune system. In animal studies, it also had anti-inflammatory and preventive properties. Cordyceps stimulates the immune system by increasing the...
10.
Kumar D, Goel V, Meena S, Mathur P, Kabra S, Lodha R, et al.
J Lab Physicians
. 2023 Aug;
15(3):443-449.
PMID: 37564235
Human microsporidiosis presents as an important and rapidly emerging opportunistic infection. However, the exact burden of this infection especially in the pediatric population of Northern India remains unknown. In this...